Occurrence and antimicrobial susceptibility of thermophilic Campylobacter species isolated from healthy children attending municipal care centers in Southern Ecuador by Toledo, Zorayda et al.
Rev Inst Med Trop São Paulo. 2017;59:e77 Page 1 of 5
BRIEF COMMUNICATION
http://dx.doi.org/10.1590/S1678-9946201759077
(1)Universidad Técnica Particular de 
Loja, Departamento de Ciencias de la 
Salud, sección de Genética Humana, 
Microbiología y Bioquímica Clínica, Loja, 
Equador 
(2)Universidad Austral de Chile, Instituto de 
Microbiología Clínica, Valdívia, Región de 
Los Ríos, Chile
Correspondence to: Heriberto Fernández 
Universidad Austral de Chile, Instituto de 
Microbiología Clínica, Edificio de Ciencias 
Biomédicas, Campus Isla Teja Valdivia, 
Región de Los Ríos, 5090000, Chile 
Tel: +56 63 2214377, +56 63 2293300
E-mail: hfernand@uach.cl 
Received: 16 May 2017
Accepted: 28 July 2017
Occurrence and antimicrobial susceptibility of thermophilic 
Campylobacter species isolated from healthy children 
attending municipal care centers in Southern Ecuador
Zorayda Toledo1, Rosa Janneth Simaluiza1, Xavier Astudillo1, Heriberto 
Fernández2
ABSTRACT
The prevalence and antimicrobial susceptibility of Campylobacter jejuni and C. coli strains 
in healthy, well-nourished children of middle socioeconomic level from Southern Ecuador 
were determined. Among the 127 children studied, 17 (13.4%) harbored Campylobacter sp. 
corresponding to C. jejuni (7.1%) and C. coli (6.3%) with a higher concentration of C. jejuni 
among boys (8.6%) and C. coli (8.8%) among girls. C. jejuni showed high resistance to 
nalidixic acid and ciprofloxacin (77.8%), but susceptibility to all other antimicrobials tested. 
C. coli strains showed resistance to more antibiotics than C. jejuni strains including resistance 
to nalidixic acid (75%), ciprofloxacin (75%), erythromycin (12.5%) and ampicillin (28.6), 
but susceptible to gentamicin and amoxicillin/clavulanic acid.
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Currently, the genus Campylobacter comprises 27 species and 12 subspecies. 
They are considered as ubiquitous bacteria frequently found in the intestinal tract 
of a wide range of animals, including birds, mammals and reptiles, which are also 
recognized as reservoir for these bacteria1-3. 
Several Campylobacter species have been reported as infectious agents for 
humans in both, industrialized and developing countries, being the thermophilic 
Campylobacter species - C. jejuni, C. coli, C. lari and C. upsaliensis - most 
commonly associated with human infections, especially with acute infectious 
diarrhea. However, they could also produce extra-intestinal infections and 
severe complications leading to sequelae such as Guillain-Barré or Miller Fisher 
Syndromes4,5. 
Campylobacter gastroenteritis is a major public health problem with increasing 
rates worldwide, being the most common cause of bacterial diarrhea in developed 
countries and the second or third cause in developing countries, particularly in South 
America3,6,7. The available clinical, laboratory and epidemiological data have been 
produced mainly in developed countries, where national surveillance programs for 
campylobacteriosis exist8. In general, developing countries do not have this kind 
of programs or they are just implementing them, which does not allow reliable 
and conclusive epidemiological data9. On the other hand, in developing countries, 
Campylobacter is not routinely diagnosed as enteric pathogens, thus, their frequency 
in infant community-acquired diarrhea is commonly underestimated10. 
Campylobacter isolation rates in diarrheic patients from developing countries 
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range from 5 to 23%7,8. Isolation of Campylobacter 
from children without diarrhea in those countries seems 
to be a frequent epidemiological fact7,11 but it is not 
well-documented in many of them as to allow real 
epidemiological data. Moreover, in developing countries, 
Campylobacter is a common cause of diarrheal disease 
among children at risk for growth failure12. 
Among children, Campylobacter infections are mainly 
responsible for digestive manifestations especially acute 
diarrhea and in a lesser extent, chronic or recurrent diarrhea. 
More rarely, immune-mediated complications (reactive 
arthritis and Gillain Barré syndrome) and extra intestinal 
infections like bacteremia can occur13,14. 
Campylobacter gastroenteritis in humans is considered 
a zoonotic foodborne illness6,7. In the last years, over 
40% of laboratory-confirmed Campylobacter strains were 
resistant to several antimicrobials, mainly to tetracyclines, 
quinolones and macrolides, limiting treatment options6,7. In 
developing countries, high resistance levels have been found 
among Campylobacter strains isolated from intestinal and 
extra-intestinal infections in children14-16. 
The aim of this descriptive study, performed during five 
months, from May to September 2016, was to determine the 
occurrence and antimicrobial susceptibility of thermophilic 
Campylobacter species in healthy well-nourished children 
of middle socioeconomic level in Southern Ecuador.
Stool samples were obtained from each of 127 children 
who attended municipal day-care centers of Loja city 
(3°59’ Lat S; 79°12’ Long W). Children aged 1–16 years 
with median age of 7.2 years, being 57 females and 70 
males. Parents of all study participants provided written 
informed consent and the study was approved by the Ethics 
Committee of the Universidad Técnica Particular de Loja.
Once obtained, each stool sample was seeded into the 
semisolid TEM (transport enrichment medium) described 
by Fernández17 consisting of Brucella broth 28 g, agar 
1.5 g, sodium metabisulphite 0.5 g, ferrous sulfate 0.5 g, 
sodium pyruvate 0.5 g, trimethoprim 10 mg, rifampicin 
15 mg, colistin 10,000 IU, amphotericin 10 mg and 
defibrinated horse blood 30 mL (formula/L) and transported 
to the laboratory. Following an enrichment period of 24 h 
at 42 °C under microaerobic conditions obtained using 
generator envelopes (Oxoid), sample aliquots were seeded 
onto Butzler’s medium plates that were incubated for 48 h 
under the same conditions described above. Suspected 
colonies were identified morphologically (Gram stain), 
biochemically (oxidase, catalase, sensitivity to nalidixic 
acid and cephalothin, hippurate and indoxyl acetate 
hydrolysis) and confirmed by the multiplex PCR test 
proposed by Yamazaki-Matsune et al.18. In brief, after 
extraction of genomic DNA, 5 μL of template DNA were 
added to a mixture containing 2 μM of each primer and 
25 μL of 2x Multiplex PCR Master Mix (QIAGEN, USA) 
adjusting final volume to 50 μL with RNase-free H2O. DNA 
amplification was performed in thermocycler (Eppendorf) 
using the following cycling conditions: one cycle of initial 
denaturation at 95 °C for 15 min., followed by 25 cycles of 
denaturation at 95 °C for 0.5 min; annealing was done at 
58 °C for 1.5 min and extension at 72 °C for 1 min, ending 
with a final extension time at 72 °C for 7 min. Reaction 
mixtures were analyzed by gel electrophoresis (3% w/v 
agarose) stained with ethidium bromide and visualized 
under UV transilluminator.
Susceptibility to ampicillin (10 μg), amoxicillin/clavulanic 
acid (20/10 μg), erythromycin (15 μg), ciprofloxacin (5 μg), 
nalidixic acid (30 μg), tetracycline (30 μg) and gentamycin 
(10 μg) was determined by the disk diffusion method 
following the 2014 recommendations of The European 
Committee on Antimicrobial Susceptibility Testing-EUCAST 
and the Antibiogram Committee of the French Microbiology 
Society19 using Müller-Hinton agar supplemented with 5% 
horse blood and 20 mg/L of β-NAD. Inocula were prepared 
suspending several well-isolated colonies of each strain in 
sterile saline buffer (NaCl 0.9%) until obtaining a turbidity 
equal to 0.5 McFarland nephelometer. Suspensions were 
seeded on the plates using soaked swabs and after allowing 
to dry, antibiotic discs were placed on the plates. After 
24 h of incubation under microaerobic conditions at 37 °C, 
diameters of the inhibition zones were measured to establish 
resistance (R) and susceptibility (S) in accordance with the 
breakpoints proposed by EUCAST (ampicillin R < 14 mm, 
S = 19 mm; amoxicillin/clavulanic acid R < 14 mm, 
S = 19 mm; erythromycin R < 20 mm, S = 20 mm; 
ciprofloxacin R < 26 mm, S = 26 mm; nalidixic acid 
R < 26 mm, S = 26 mm; tetracycline R < 30 mm, S = 30 mm; 
and gentamycin R < 17 mm, S = 17 mm). Campylobacter 
jejuni ATCC 33560 strain was used as quality control.
Of the 127 children studied, 17 (13.4%) harbored 
Campylobacter sp. corresponding 9 (12.9%) to boys 
and 8 (14.0%) to girls. Asymptomatic excretion of 
Campylobacter species is commonly reported among 
children from developing countries7. In South America, 
frequencies ranging from 4.9% to 13.8% have been 
reported7. The prevalence of Campylobacter isolation 
rate found in our study (13.4%) was significantly higher 
to the 6% (C. jejuni 4%; C. coli 2%) reported in a recent 
survey conducted in the Ecuadorian capital, city of Quito, 
among children without diarrhea20. This asymptomatic 
excretion is an epidemiological feature commonly observed 
in developing countries7, probably associated with poor 
sanitation conditions and frequent contact with domestic 
animals considered as reservoirs6,7,21. Furthermore, the high 
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prevalence of Campylobacter in asymptomatic children may 
be related to the development of protective immunity due 
to exposure in early life3. 
In Loja region, it was demonstrated that dogs can be 
a common source of environmental contamination for 
C. jejuni and C. coli22. On the other hand, holding small 
backyard for raising poultry flocks and guinea pigs are 
popular among Ecuadorian people as meat source. High 
Campylobacter isolation rates have been found among these 
two types of meat source23,24.
In this study, the isolation frequencies of both species, 
C. jejuni (7.1%) and C. coli (6.3%), were similar as it 
was also the global Campylobacter isolation rates among 
males and females (P>0.005). Although it is noteworthy 
that there was a higher concentration of C. jejuni among 
boys (8.6%) and C. coli (8.8%) among girls. Reasons for 
this are unknown and as far as we know, this particular 
species distribution related to gender has not been described. 
Some risk factors, like rurality and contact with chickens or 
chicken meat, have been associated with C. coli infection 
in developed countries25. Further epidemiological studies 
are necessary in developing countries to explain this issue 
as well as the causes responsible for its occurrence.
In industrialized countries, infection is more prevalent 
in children under four years old3 whereas, in developing 
countries, it is in children under two years old7,26. Despite the 
fact that asymptomatic colonization with Campylobacter is 
a common feature reported in developing countries7, little is 
known about their age distribution. In a Peruvian survey26, 
asymptomatic carriers were the most frequent among children 
<1 year (16.7%) declining up to six years old to 3.8%. The 
opposite was observed in our study where the lowest isolation 
rate (7.1%) was found among children <2 years old, occurring 
an increase in the frequency of isolation as age rises (up to 
five years old 12.3%; over five years old 23.1%). Further 
studies are needed to explain this age distribution.
All the C. jejuni strains were susceptible to erythromycin, 
gentamicin, ampicillin and amoxicillin/clavulanic acid, 
but 77.8% of the isolates were resistant to nalidixic acid 
and ciprofloxacin. C. coli strains were resistant to more 
antimicrobials than C. jejuni strains. Resistant strains 
were found for nalidixic acid (75%), ciprofloxacin (75%), 
erythromycin (12.5%) and ampicillin (28.7%), but all 
were susceptible to gentamicin and amoxicillin/clavulanic 
acid. EUCAST has not proposed breakpoints for nalidixic 
acid. Therefore, we homologate the EUCAST breakpoints 
of ciprofloxacin to define resistance and susceptibility to 
nalidixic acid. A good correlation among nalidixic acid-
resistant and ciprofloxacin-resistant strains was observed, 
Table 1 - Distribution of Campylobacter by sex
Sex Number Examined Positive samples Number (%)
Species isolated 
Number (%)
C. jejuni C. coli
Male* 70 9 (12.9) 6 (8.6%) 3 (4.3%)
Female* 57 8 (14.0) 3 (5.3%) 5 (8.8%)
Total 127 17 (13.4) 9 (7.1%) 8 (6.3%)
*P>0.005
Table 2 - Distribution of Campylobacter by age
Age (months) Number Examined % Positive C. jejuni C. coli
0-24 28 7.1 0 2
25-60 73 12.3 4 5
>60 26 23.1 5 1
Total 127 13.4 9 8
Table 3 - Antimicrobial resistance of C. jejuni and C. coli isolated 
in Loja city, Ecuador
Antimicrobial agent C. jejuni N=9 %
C. coli N=8 
%






clavulanic acid 0 0
Tetracycline 60.0 50.0
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indicating that nalidixic acid is a good quinolone resistance 
indicator, therefore, useful to establish surveillance of 
resistance to these antimicrobials. High resistance to 
ciprofloxacin was previously reported in Loja city in 
C. jejuni and C. coli strains isolated from dog feces22, 
chicken23 and chicken livers for human consumption27, 
thus suggesting that this resistance could also be found with 
high frequency among strains isolated from human beings. 
The three ampicillin-resistant strains were susceptible to 
amoxicillin/clavulanic acid indicating that these resistant 
strains were beta-lactamase producers, as it has been 
observed in other Latin American countries28.
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